Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -2.98% vs -29.42% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -28.34% vs -48.70% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -73.62% vs -41.67% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -12.83% vs -44.33% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Sichuan Kelun Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -18.66% vs 24.87% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -2.98% vs -29.42% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -25.25% vs 383.12% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -28.34% vs -48.70% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -73.64% vs 97.99% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -73.62% vs -41.67% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 20.94% vs -36.33% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -12.83% vs -44.33% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






